 BioSpecifics Technologies NASDAQ:BSTC was upgraded by equities research analysts at BidaskClub from a hold rating to a buy rating in a report issued on Thursday, BidAskClub reports. BSTC has been the topic of several other research reports. Zacks Investment Research downgraded BioSpecifics Technologies from a buy rating to a hold rating in a report on ... 